451 related articles for article (PubMed ID: 12612978)
1. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
Linossier MT; Palle S; Berthoux F
Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
[TBL] [Abstract][Full Text] [Related]
2. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
[TBL] [Abstract][Full Text] [Related]
3. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
4. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
5. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Moldoveanu Z; Wyatt RJ; Lee JY; Tomana M; Julian BA; Mestecky J; Huang WQ; Anreddy SR; Hall S; Hastings MC; Lau KK; Cook WJ; Novak J
Kidney Int; 2007 Jun; 71(11):1148-54. PubMed ID: 17342176
[TBL] [Abstract][Full Text] [Related]
6. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
7. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
Barratt J; Smith AC; Feehally J
Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
[TBL] [Abstract][Full Text] [Related]
9. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
[TBL] [Abstract][Full Text] [Related]
10. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
Odani H; Hiki Y; Takahashi M; Nishimoto A; Yasuda Y; Iwase H; Shinzato T; Maeda K
Biochem Biophys Res Commun; 2000 Apr; 271(1):268-74. PubMed ID: 10777713
[TBL] [Abstract][Full Text] [Related]
11. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
12. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
Smith AC; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
14. Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients.
Iwase H; Katsumata T; Itoh A; Hiki Y; Ikuko N; Sano T; Takatani T; Kobayashi Y
J Nephrol; 2002; 15(6):703-8. PubMed ID: 12495288
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura.
Saulsbury FT
J Rheumatol; 1997 Nov; 24(11):2246-9. PubMed ID: 9375892
[TBL] [Abstract][Full Text] [Related]
16. Structural features of IgA molecules which contribute to IgA nephropathy.
Feehally J; Allen AC
J Nephrol; 1999; 12(2):59-65. PubMed ID: 10378660
[TBL] [Abstract][Full Text] [Related]
17. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy.
Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M
J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035
[TBL] [Abstract][Full Text] [Related]
18. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy.
Ding JX; Xu LX; Lv JC; Zhao MH; Zhang H; Wang HY
Clin Immunol; 2007 Dec; 125(3):268-74. PubMed ID: 17913589
[TBL] [Abstract][Full Text] [Related]
19. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
[TBL] [Abstract][Full Text] [Related]
20. Similarities between N-glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum.
Iwanami N; Iwase H; Takahashi N; Kato K; Itoh A; Takatani T; Makita S; Kobayashi Y; Okamoto M; Nakamura S; Hiki Y; Ishii M
J Nephrol; 2008; 21(1):118-26. PubMed ID: 18264945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]